Financial reports
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
7 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
ARS
2022 FY
Annual report to shareholders
27 Apr 23
10-K
2022 FY
Annual report
23 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
10-K
2021 FY
Annual report
30 Mar 22
10-Q
2021 Q3
Quarterly report
12 Nov 21
Current reports
8-K
Entry into a Material Definitive Agreement
4 Mar 24
8-K
Termination of a Material Definitive Agreement
8 Feb 24
8-K
Departure of Directors or Certain Officers
17 Jan 24
8-K
Departure of Directors or Certain Officers
11 Jan 24
8-K
Entry into a Material Definitive Agreement
9 Nov 23
8-K
Acutus Medical Reports Third Quarter 2023 Financial Results
8 Nov 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
30 Oct 23
8-K
Acutus Medical Reports Second Quarter 2023 Financial Results
7 Aug 23
8-K
Departure of Directors or Certain Officers
5 Jul 23
8-K
Submission of Matters to a Vote of Security Holders
20 Jun 23
Registration and prospectus
S-8
Registration of securities for employees
23 Mar 23
424B5
Prospectus supplement for primary offering
21 Dec 22
S-3
Shelf registration
9 Dec 22
424B3
Prospectus supplement
19 Aug 22
S-3
Shelf registration
11 Aug 22
D
$4.2M in options, 2 investors
15 Jul 22
S-8
Registration of securities for employees
30 Mar 22
S-8
Registration of securities for employees
1 Feb 22
424B4
Prospectus supplement with pricing info
15 Jul 21
S-1
IPO registration
12 Jul 21
Other
SD
Conflict minerals disclosure
26 May 23
EFFECT
Notice of effectiveness
22 Dec 22
CORRESP
Correspondence with SEC
19 Dec 22
UPLOAD
Letter from SEC
16 Dec 22
EFFECT
Notice of effectiveness
22 Aug 22
CORRESP
Correspondence with SEC
17 Aug 22
UPLOAD
Letter from SEC
15 Aug 22
EFFECT
Notice of effectiveness
15 Jul 21
CORRESP
Correspondence with SEC
12 Jul 21
CORRESP
Correspondence with SEC
12 Jul 21